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Although millions of cells are shed daily from a tumour, the
formation of metastases is a rare event. The seminal observations
of Butler and Gullino (1975) of tumour cell shedding from a
tissue-isolated mammary carcinoma, of Liotta et al (1974, 1976)
of shedding from a fibrosarcoma and of Fidler (1973) of
melanoma cells injected intravenously helped to establish the
concept of metastasis as a highly inefficient process. In this
process, specific cell phenotypes are selected for at each step in
order to eventually form a distant metastatic colony (Weiss, 1992;
Aznavoorian et al, 1993; Zetter, 1993; Fidler and Ellis, 1994;
Chambers and Matrisian, 1997).
The goal of this study was to investigate whether tumour cell
shedding is a selective step in the metastatic cascade. To this end,
we compared colony-forming potential and apoptosis of cells shed
from a tumour with cells isolated directly from their host tumour.
The LS174T tumour line along with its highly metastatic variant
LSLiM6 (Bresalier et al, 1991) were grown as tissue-isolated
tumours in the ovarian fat pad of nude mice (Kristjansen et al,
1994). This preparation permits collection of all cells shed by a
tumour. Tumours were perfused at different flow rates, and then
digested into single-cell suspensions to obtain two different cell
populations. Shed cells were compared with their native tumour
cell population using in vitro clonogenicity in increasing agarose
concentrations (0.3–0.9%), since clonogenicity (particularly in
hard agarose) has been repeatedly correlated with metastatic
potential and prognosis (Li et al, 1989; Nomura et al, 1989; Zhang
et al, 1991). The LS174T cell groups were also implanted into
mouse dorsal skinfold chambers (Leunig et al, 1992) to compare
the relative tumorigenicity of shed and native tumour cells.
Finally, the apoptotic fractions of each cell population were
compared. Our results demonstrate that perfusion rate does not
affect shedding rate or clonogenicity of shed cells. Furthermore,
the shed cells are highly apoptotic and have reduced clonogenicity
and tumorigenicity.
MATERIALS AND METHODS
Animals and tumours
For all experiments, 8- to 10-week-old NCr/Sed-nu/nu female
athymic mice bred in our animal facility were used. All protocols
were approved by the Massachusetts General Hospital
Subcommittee of Research and Animal Care. Before each proce-
dure, the mice were anaesthetized with a solution of ketamine
(100 mg kg–1 body weight, Parke-Davis, Morris Plains, NJ, USA)
and xylazine (10 mg kg–1, Miles, Shawnee Mission, KS, USA).
The human colon adenocarcinoma line LS174T (ATCC #CL 188,
Rockville, MD, USA) and its highly metastatic subline LS LiM 6
(kind gift of Dr Robert Bresalier, University of California, San
Francisco, CA, USA) were serially transplanted to the flanks of
donor mice to maintain stocks of donor tissue. The tissue-isolated
tumours, which are connected with the systemic circulation by
only a single artery and vein, were prepared as originally described
by Kristjansen et al (1994) and experiments performed when the
tumours reached a size of 8–12 mm in diameter. Because of the
limitations imposed by the small numbers of shed cells (104–105
per experiment), each variable (clonogenicity, apoptotic fraction,
tumorigenicity and cell shedding rate) was examined in indepen-
dent experiments.
Tumour perfusion
The cannulation of aorta and vena cava and the ligation of vessels
surrounding the tumour artery and vein, as well as the perfusion
setup, has previously been described in detail (Kristjansen et al,
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1994, 1996) and is depicted in Figure 1. In the present experi-
ments, the tumours were perfused with oxygenated horse serum
(Sigma Chemicals, St Louis, MO, USA) at 37°C. Sterility of the
serum was maintained by filtering the perfusate through a sterile
syringe filter (25 mm, 0.2 mm, Corning Glass Works, Corning,
NY, USA) before flowing into the tumour through g-irradiated
PE-10 polyethylene tubing. For the studies comparing the effects
of perfusion rate on cell shedding rate, the initial perfusate flow
rate was set at 65 ml min–1, which was at the low end of the
physiological tumour blood flow range of 30–322 ml min–1 g–1
(Kristjansen et al, 1994). The outlet perfusate was collected in
2-min samples for 20 min, wherefore the flow rate was increased
to 90, 110 and, if possible, 120 ml min–1 (with 2-min sampling for
20 min at each level). For all other experiments, perfusion rate was
fixed at 100 ml min–1 and collected for 2 h. At the end of each
perfusion, the tumour was excised and weighed.
Cell isolation from solid tumours
Tissue-isolated tumours were minced and rinsed with Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma) with 10% fetal calf
serum (FCS; Sigma). For every 1 g of tissue, 2 ml of collagenase
type III solution (1 mg ml–1 in RPMI-1640, 109 units mg–1; Cooper
Biomedical, Malvern, PA, USA) was added to the tissue. The
tissue suspension was incubated at room temperature for 4 h,
filtered through a 70-mm nylon cell strainer (Becton-Dickinson,
Franklin Lakes, NJ, USA) and the resulting cell suspension was
washed twice in medium and counted in a haemocytometer. For
assessment of colony-forming ability, cells were diluted to concen-
trations approximately equal to that of the average shed cell count.
Cell counts
The first set of experiments evaluated the effect of varying perfu-
sion rate utilizing LS174T tumours. First, the volume of each 2-
min perfusate sample was measured by weight. Every fifth sample
(a total of three from each flow rate) was set aside for determina-
tion of tumour cell count, while the rest were analysed for colony
formation. The total live cell count was measured in every other
sample using trypan blue exclusion.
Because the LS174T tumour line is of human origin, tumour
cells could be marked with a generic HLA antibody and counted in
a flow cytometer. The shed cells were compared with the minced
tumour cells. Cultured mouse endothelial cells (ATCC) were used
as a negative control and human lymphocytes as a positive control.
Each sample was labelled with fluoroscein isothiocyanate (FITC)-
conjugated mouse anti-human HLA Class I-ABC antibody
(Biosource Int., Camarillo, CA, USA) and fixed in 3%
paraformaldehyde. Flow cytometry was performed with a
FACScan (Becton-Dickinson).
To evaluate the effects of perfusion rate on colony formation,
each sample was washed and incubated in one well of a 12-well
plate containing 3 ml DMEM and 30 000 irradiated (60 Gy, 1
fraction) LS174T ‘feeder’ cells (Puck and Marcus, 1955). After
21 days, the plates were stained with 1% 3-(4,5-dimethylthiazal-
2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) in DMEM
(1.5 mg ml–1, 2 ml per well) and examined for colony size.
Colonies were identified as spherical cell clusters which were
greater than 100 mm in diameter. Medium with 30 000 irradiated
LS174T cells served as a negative control.
Clonogenicity in varying agarose concentrations
For determination of in vitro clonogenicity, each cell population
from the LS174T or LS LiM 6 tumours was perfused and prepared
as described earlier and incubated in concentrations of 1000, 5000,
10 000 or 20 000 cells per well in 6 well plates. Cell plating
number was evaluated in pilot experiments using both LS174T
and LS LiM 6 cells taken directly from culture. Each plate
contained 1.5 ml of 1.2% agarose gel in DMEM at the bottom.
Above this was a cell layer containing 1.5 ml of 0.3%, 0.6%, or
0.9% agarose in DMEM with 10% FCS. To the top of each well
was added 1 ml DMEM with 10% FCS, which was changed every
fifth day. The cells were allowed to grow in a 37°C humidified
incubator. After 3 weeks, colonies were counted according to their
size distributions using a light microscope.
Determination of apoptotic fraction
Cytospin preparations (2 000 cells each) were made from each cell
population, and from some LS174T tumours, cryostat sections
were made as a control to verify that the digestion method was not
killing the native apoptotic cells (which would result in a lower
measured apoptotic fraction). Each slide was evaluated for apop-
tosis using an Apoptag Fluorescein Apoptosis Kit (Oncor Inc,
Gaithersburg, MD, USA). Cells were fixed and solubilized in 70%
ethanol for 4 h. Manufacturer’s instructions were then followed,
and 0.1% propidium iodide was used as a counterstain. Slides
were observed under a fluorescence microscope (Zeiss,
Oberkochen, Germany) using a 32´ objective and on each slide,
six regions or enough to evaluate approximately 100 cells were
used. In each region, a cell count was first determined (i.e.
propidium iodide-stained nuclei) and then the apoptotic-positive
fraction was determined using a fluorescein filter. For the tumour
sections, an average cell density was determined and the apoptotic
fraction evaluated by direct counting of ten regions.
Pump
37
oC
Sampling
Enzymatic
digestion of
tumour tissue
95% O2
5% CO2
Total cell count and
tumour cell fraction
(flow cytometer)
Apoptotic fraction
(TUNEL)
Clonogenic fraction
(0.3%–0.9% agarose)
Figure 1 Schematic of the perfused, tissue-isolated tumour setup to collect
shed cells. The abdominal aorta and vena cava are cannulated as indicated
and ligated below the level of the iliac truncus. All vascular branches except
those draining and feeding the tissue-isolated tumour are ligated. T denotes
the tissue-isolated tumour in a sealed parafilm bag. Two-minute samples
were collected and either counted for total number of live cells and then
plated for determination of clonogenicity or sorted in a flow cytometer for
determination of tumour cell fraction of the total cell population. Modified from
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Tumorigenicity
To assess relative tumorigenicity, six LS174T tumours were
perfused and a single-cell suspension was prepared from the host
tumour as before. Cells from each population were washed twice
with DMEM, spun down into a concentrated pellet and seeded into
dorsal skinfold chambers as described previously (Leunig et al,
1992). Approximately 2 ´ 105 minced tumour cells and 3 ´ 105
shed tumour cells were used for each chamber, based on approxi-
mations of tumour cell fractions from each population (determined
by flow cytometry) and previous experience with tumour cell
numbers required to produce a tumour in a dorsal skinfold
chamber (Leunig et al, 1992). Fifty percent more shed cells were
seeded into the chamber than minced cells in order to ensure that
the results were based solely on differences in average cell
phenotype.
RESULTS
Tumour cell shedding rates
The perfused LS174T and LS LiM 6 tumours shed an average
(± s.d.) of 2.6 ± 0.9 ´ 105 and 9.8 ± 0.5 ´ 104 tumour cells h–1 g–1
tumour respectively. This corresponds to 6.2 and 2.3 million cells
day–1 g–1. The cell fractions staining positive for HLA were
65 ± 5% and 56 ± 14% for native and shed cells respectively
(cultured cells stained 82 ± 2% positive). Cells were consistently
shed as single cells; less than 0.1% were found to be in multi-
cellular clusters. Cell isolation from solid tumour tissue also
resulted in approximate single-cell suspensions; only 0.8 ± 0.4%
of cell units were clusters ranging in size from 2 to 10 cells.
Therefore, this discrepancy was neglected in evaluating clono-
genicity and single cell suspensions were assumed (Gerweck et al,
1994).
Perfusion rate does not affect cell shedding rate
Figure 2 shows typical cell populations shed as a function of time
from a single representative experiment. Changes in perfusion rate
are indicated by vertical dotted lines. Average clonogenicity on
plastic of native LS174T cells (tumour digest) was 2.7 ± 1.4%,
while that of the shed cells was 0.16 ± 0.07% (cultured LS174T
cells showed an average clonogenicity of 4.5 ± 1.0%). No correla-
tion was found between the cell shedding rate and perfusion rate as
well as between their clonogenicity and flow rate.
Shed cells have reduced clonogenicity
Clonogenicity of the cell populations is shown in Figure 3. The
native LS LiM 6 cells showed higher clonogenicity in 0.6–0.9%
agarose concentrations than the corresponding groups of the
LS174T tumours (P < 0.01 for all colony size groups using a
Student’s t-test), and native tumour cells were consistently more
clonogenic than their shed counterparts (e.g. in 0.3% agarose,
P < 0.05 for both tumour lines). These differences were most
notable at 0.6% and 0.9% agarose concentrations, particularly in
the LS LiM 6 groups (P < 0.01 for LS LiM 6 and P < 0.05 for
LS174T).
Shed cells are apoptotic
In both tumour types, shed cells showed greater apoptotic fractions
than the native cell populations. For the LS174T tumours,
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Figure 2 Representative shed cell counts from a perfused tissue-isolated
LS174T tumour. Each vertical line represents a change in perfusion rate
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Figure 3 Mean clonogenicity of shed cells compared to their host tumour
cells in different agarose concentrations. Shed cells were significantly less
clonogenic than host tumour cells in 0.6% and 0.9% agarose in both tumour
lines (P < 0.05). LS174T cells were significantly less clonogenic than their
more metastatic subline cells LS LiM 6 at agarose concentrations of 0.6%
and 0.9% (P < 0.05). Error bars indicate standard deviationsClonogenicity of shed cells 759
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20 ± 11% of native cells (verified by the frozen section stainings,
which showed apoptotic indices between 10 and 40%) and
53  ± 12% of shed cells were apoptotic. For LS LiM 6 tumours,
9 ± 3% of native cells and 59 ± 8% of shed cells were apoptotic.
Differences in apoptotic fraction between cells shed from the
LS174T tumour and those from the LS LiM 6 tumour were not
significant. However, differences between native populations were
significant (P < 0.05 using a Student’s t-test). Furthermore, for
each tumour line, the shed and native cells were significantly
different (P < 0.005 for LS174T and P < 0.0005 for LS LiM 6).
Shed cells have reduced tumorigenicity
Shed cells showed reduced tumorigenicity when implanted into
dorsal skinfold chambers. Every chamber implanted with minced
cells (6/6) showed angiogenic activity and tumour formation
(1–4 mm diam) at 3 weeks, while none of the six shed cell groups
formed tumours and only one showed signs of angiogenesis.
DISCUSSION
Metastasis is known to be an inefficient process. The events of
metastasis – detachment, intravasation, survival within the blood-
stream, adhesion to the vessel wall, migration and proliferation –
are each selective processes which require specific cell pheno-
types. The observations of Butler and Gullino (1975) and Liotta
et al (1974, 1976), although seminal, did not give insight into the
phenotype of the shed cells as well as the significance of shedding
rates. The perfused tissue-isolated tumour model enabled us to
study the initial steps in the metastatic process and to characterize
the shed cells relative to the overall native tumour cell population.
In particular, in vitro clonogenicity, apoptotic fraction, and in vivo
tumorigenicity were examined. These traits have been strongly
linked to metastatic potential. For example, more highly metastatic
tumour lines are more clonogenic in 0.9% agarose (Li et al, 1989;
Zhang et al, 1991) and show an increased resistance to apoptosis
(Glinsky and Glinsky, 1996; Glinsky, 1997). These findings are
consistent with our observed differences between native tumour
cells of the LS174T and its highly metastatic variant, LS LiM 6.
The total numbers of tumour cells shed from the LS174T and LS
LiM 6 tumours corroborate previously published data on cell shed-
ding rate (Butler and Gullino, 1975). However, these shed cells
showed decreased proliferative capacity in vitro and in vivo,
suggesting poor metastatic capacity compared with the average
cell population from the native tumour. TUNEL stainings of tissue
sections showed apoptotic indices directly comparable to those of
cells isolated by enzymatic digestion indicating that there was no
selection of apoptosis-resistant cells after enzymatic treatment.
The observation that most of these shed cells are apoptotic – 48%
compared with the average native cell apoptotic fraction of 20% in
LS174T tumours, and 59% compared with the native fraction of
9% in the more highly metastatic variant LS LiM 6 – strengthens
the hypothesis that cell shedding is a natural process of eliminating
ineffective tumour cells and not a selective step in the metastatic
cascade. With this hypothesis, we would expect more highly
metastatic tumours to have lower apoptotic rates (Glinsky and
Glinsky, 1996; Glinsky, 1997) and therefore shed fewer cells,
which is consistent with the tumour lines examined here. Our
finding also suggests that the low metastasis-forming potential of
cancer cells is not only due to their inability to survive in the circu-
lation, adhere, and extravasate at the secondary site, but also due to
the fact that most of the cells are already in the process of dying
when they exit the tumour.
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